- Home
- SNTG vs BNOX Comparison
SNTG vs BNOX Comparison
Compare SNTG & BNOX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SNTG
- BNOX
- Stock Information
- Founded
- SNTG 2009
- BNOX 1996
- Country
- SNTG China
- BNOX Australia
- Employees
- SNTG N/A
- BNOX N/A
- Industry
- SNTG Finance: Consumer Services
- BNOX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- SNTG Finance
- BNOX Health Care
- Exchange
- SNTG Nasdaq
- BNOX Nasdaq
- Market Cap
- SNTG 5.4M
- BNOX 6.3M
- IPO Year
- SNTG 2021
- BNOX 2021
- Fundamental
- Price
- SNTG $1.88
- BNOX $0.27
- Analyst Decision
- SNTG
- BNOX Strong Buy
- Analyst Count
- SNTG 0
- BNOX 1
- Target Price
- SNTG N/A
- BNOX $8.00
- AVG Volume (30 Days)
- SNTG 8.8K
- BNOX 691.4K
- Earning Date
- SNTG 12-24-2024
- BNOX 01-01-0001
- Dividend Yield
- SNTG N/A
- BNOX N/A
- EPS Growth
- SNTG N/A
- BNOX N/A
- EPS
- SNTG N/A
- BNOX N/A
- Revenue
- SNTG $146,554.00
- BNOX N/A
- Revenue This Year
- SNTG N/A
- BNOX N/A
- Revenue Next Year
- SNTG N/A
- BNOX N/A
- P/E Ratio
- SNTG N/A
- BNOX N/A
- Revenue Growth
- SNTG N/A
- BNOX N/A
- 52 Week Low
- SNTG $1.52
- BNOX $0.18
- 52 Week High
- SNTG $8.45
- BNOX $1.60
- Technical
- Relative Strength Index (RSI)
- SNTG 39.05
- BNOX 47.76
- Support Level
- SNTG $1.88
- BNOX $0.27
- Resistance Level
- SNTG $1.98
- BNOX $0.35
- Average True Range (ATR)
- SNTG 0.10
- BNOX 0.03
- MACD
- SNTG -0.00
- BNOX 0.00
- Stochastic Oscillator
- SNTG 0.00
- BNOX 18.78
About SNTG Sentage Holdings Inc.
Sentage Holdings Inc is a financial service provider that offers a comprehensive range of financial services across consumer loan repayment and collection management, loan recommendation, and prepaid payment network services in China.
About BNOX Bionomics Limited American Depository Shares
Bionomics Ltd is a clinical-stage biopharmaceutical company. It is primarily engaged in the development of therapeutics for diseases of the central nervous system and cancer. The company's reportable segment is the Drug Discovery and Development segment which is engaged in the discovery, development, and commercialization of compounds to match a target product profile. The company generates all of its revenues from Australia.